title: Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants.
authors.forename: D
authors.initials: D
authors.lastname: Maratea
authors.forename: V
authors.initials: V
authors.lastname: Fadda
authors.forename: S
authors.initials: S
authors.lastname: Trippoli
authors.forename: A
authors.initials: A
authors.lastname: Messori
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage; D000069604:Dabigatran; D017984:Enoxaparin / Q000008:administration & dosage; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage; D019637:Orthopedic Procedures / Q000009:adverse effects*; D011720:Pyrazoles / Q000008:administration & dosage; D011728:Pyridones / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D015091:beta-Alanine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D017984:Enoxaparin; D009025:Morpholines; D011720:Pyrazoles; D011728:Pyridones; D013876:Thiophenes; D015091:beta-Alanine; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran